Yan, Jun http://orcid.org/0009-0005-9139-3966
Oyler-Castrillo, Paul
Ravisankar, Purnima http://orcid.org/0000-0001-7799-4558
Ward, Carl C.
Levesque, Sébastien
Jing, Yangwode http://orcid.org/0000-0002-1692-6567
Simpson, Danny
Zhao, Anqi
Li, Hui
Yan, Weihao http://orcid.org/0009-0000-2509-1816
Goudy, Laine
Schmidt, Ralf http://orcid.org/0000-0002-6697-0363
Solley, Sabrina C. http://orcid.org/0000-0002-2356-5608
Gilbert, Luke A. http://orcid.org/0000-0001-5854-0825
Chan, Michelle M. http://orcid.org/0000-0001-9451-9716
Bauer, Daniel E.
Marson, Alexander http://orcid.org/0000-0002-2734-5776
Parsons, Lance R. http://orcid.org/0000-0002-8521-714X
Adamson, Britt http://orcid.org/0000-0002-9451-5819
Article History
Received: 25 April 2023
Accepted: 29 February 2024
First Online: 3 April 2024
Competing interests
: B.A. is an advisory board member with options for Arbor Biotechnologies and Tessera Therapeutics. B.A. holds equity in Celsius Therapeutics. L.A.G has filed patents on CRISPR tools and CRISPR functional genomics and is a co-founder of Chroma Medicine. A.M. is a co-founder of Arsenal Biosciences, Site Tx, Spotlight Therapeutics, and Survey Genomics, serves on the boards of directors at Site Tx, Spotlight Therapeutics and Survey Genomics, is a member of the scientific advisory boards of Arsenal Biosciences, Site Tx, Spotlight Therapeutics, Survey Genomics, NewLimit, Amgen, Tenaya, and Lightcast, owns stock in Arsenal Biosciences, Site Tx, Spotlight Therapeutics, NewLimit, Survey Genomics, PACT Pharma, Tenaya, and Lightcast, and has received fees from Arsenal Biosciences, Spotlight Therapeutics, Site Tx NewLimit, Survey Genomics, Gilead, 23andMe, PACT Pharma, Juno Therapeutics, Tenaya, Lightcast, Trizell, Vertex, Merck, Amgen, Genentech, AlphaSights, Rupert Case Management, Bernstein, GLG, ClearView Healthcare Partners, and ALDA. A.M. is an investor in and informal advisor to Offline Ventures and a client of EPIQ. The Marson Laboratory has received research support from Juno Therapeutics, Epinomics, Sanofi, GlaxoSmithKline, Gilead, and Anthem. C.C.W. and R.S. are co-founders of Site Tx. J.Y. and B.A. have filed a patent application on aspects of this work through Princeton University, and B.A. has previously filed other patents on CRISPR-based technologies. The remaining authors declare no competing interests.